These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32567262)

  • 1. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
    J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine as a prophylactic agent against COVID-19?
    Gendrot M; Javelle E; Clerc A; Savini H; Pradines B
    Int J Antimicrob Agents; 2020 Jun; 55(6):105980. PubMed ID: 32294495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hydroxychloroquine beneficial for COVID-19 patients?
    Li X; Wang Y; Agostinis P; Rabson A; Melino G; Carafoli E; Shi Y; Sun E
    Cell Death Dis; 2020 Jul; 11(7):512. PubMed ID: 32641681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
    Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
    Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for COVID-19: The reality and challenges.
    Jean SS; Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2020 Jun; 53(3):436-443. PubMed ID: 32307245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audio Interview: Studying Potential Covid-19 Therapies.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
    [No Abstract]   [Full Text] [Related]  

  • 7. The race against COVID-19.
    Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
    [No Abstract]   [Full Text] [Related]  

  • 8. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 9. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 10. Communicating Science in the Time of a Pandemic.
    Saitz R; Schwitzer G
    JAMA; 2020 Aug; 324(5):443-444. PubMed ID: 32749498
    [No Abstract]   [Full Text] [Related]  

  • 11. Audio Interview: New Data on Remdesivir in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
    [No Abstract]   [Full Text] [Related]  

  • 12. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
    Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
    Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
    JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic].
    Estella Á; Garnacho-Montero J
    Med Intensiva (Engl Ed); 2020 Nov; 44(8):509-512. PubMed ID: 32423569
    [No Abstract]   [Full Text] [Related]  

  • 16. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Banerjee AK; Arora N
    Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
    [No Abstract]   [Full Text] [Related]  

  • 18. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Trials of Repurposed Antivirals for SARS-CoV-2.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
    Li C; Wang L; Ren L
    Virus Res; 2020 Sep; 286():198073. PubMed ID: 32592817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.